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Evaluation of an in vitro blood-based assay to detect production
of interferon-g by Mycobacterium bovis–infected white-tailed
deer (Odocoileus virginianus)
Mitchell V. Palmer,1 W. Ray Waters, Diana L. Whipple, Ralph E. Slaughter, Stephen L. Jones
Abstract. Tuberculosis due to Mycobacterium bovis in captive Cervidae was identified as an important
disease in the United States in 1990 and prompted the addition of captive Cervidae to the USDA Uniform
Methods and Rules for eradication of bovine tuberculosis. As well, M. bovis infection was identified in free-
ranging white-tailed deer in northeast Michigan in 1995. Tuberculosis in both captive and free-ranging Cervidae
represents a serious challenge to the eradication of M. bovis infection from the United States. Currently, the
only approved antemortem tests for tuberculosis in Cervidae are the intradermal tuberculin skin test and the
blood tuberculosis test (BTB). At present, the BTB is not available in North America. Tuberculin skin testing
of Cervidae is time-consuming and involves repeated animal handling and risk of injury to animals and humans.
This study evaluated the potential of a new blood-based assay for tuberculosis in Cervidae that would decrease
animal handling, stress, and losses due to injury. In addition, a blood-based assay could provide a more rapid
diagnosis. Twenty 6–9-month-old white-tailed deer, male and female, were experimentally inoculated by instil-
lation of 300 colony-forming units of M. bovis in the tonsillar crypts. Seven, age-matched uninfected deer
served as controls. Blood was collected on days 90, 126, 158, 180, 210, 238, 263, and 307 after inoculation
and was analyzed for the production of interferon-g (IFN-g) in response to incubation with M. bovis purified
protein derivative (PPDb), M. avium PPDa, pokeweed mitogen (PWM), or media alone. Production of IFN-g
in response to PPDb was significantly greater (P , 0.05) at all time points in samples from M. bovis–infected
deer as compared with uninfected control deer, whereas IFN-g production to PWM did not differ significantly
between infected and control deer. Measurement of IFN-g production to PPDb may serve as a useful assay for
the antemortem diagnosis of tuberculosis in Cervidae.
Although bovine tuberculosis has nearly been erad-
icated from the United States, the disease has persisted
and the prevalence has increased in recent years. Fac-
tors that contributed to the resurgence of tuberculosis
in animals are the importation of tuberculous cattle
from Mexico, the persistence of low levels of Myco-
bacterium bovis infection in large dairy herds in the
southwestern United States, and the presence of tu-
berculosis in captive deer and elk that are raised for
agricultural purposes, in zoo animals, in game parks,
in other exotic animal collections, and in free-ranging
white-tailed deer.15
In the past 2 decades, there has been rapid expan-
sion of the captive cervid industry in the United States.
Mycobacterium bovis infection in captive cervids was
identified as an important disease in the United States
in 1990 when an outbreak of tuberculosis in captive
elk in Canada was traced to elk imported from the
United States.2 Since then, tuberculosis has been di-
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agnosed in at least 37 captive cervid herds in 18 states.
This has prompted the addition of captive cervids to
the USDA Uniform Methods and Rules for the erad-
ication of bovine tuberculosis. As well, M. bovis in-
fection was identified in free-ranging white-tailed deer
in northeast Michigan in 1995.11 Tuberculosis in both
captive and free-ranging cervids represents a serious
challenge to eradication of M. bovis from the United
States. Currently, the only approved antemortem tests
for tuberculosis in Cervidae are the intradermal tuber-
culin skin test that uses purified protein derivative
(PPD) from M. bovis (PPDb) and M. avium (PPDa)
and the blood tuberculosis test (BTB) that is a com-
posite test measuring both cellular and humoral im-
mune responses. At present, the BTB is not available
in North America. Intradermal tuberculin testing in
Cervidae lacks sensitivity and specificity;1,4,5,8 more-
over, animals cannot be retested for 90 days. Infection
with nontuberculous mycobacteria often confounds the
interpretation of skin testing, resulting in false-positive
reactions. A blood-based assay for tuberculosis in cer-
vids would decrease animal handling, stress, losses due
to injury and allow short-interval repeat testing if nec-
essary.
A whole-blood cellular assay using a sandwich en-
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Table 1. List of mitogens and concentrations used to stimulate
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* Concentration after addition of 1.5 ml of heparinized whole
blood.
zyme immunoassay for bovine interferon-g (IFN-g)
was previously developed and found to be effective in
the diagnosis of M. bovis infection in cattle.10,20 The
IFN-g immunoassay for cattle uses 2 monoclonal an-
tibodies specific for biologically active bovine IFN-g
that do not detect bovine IFN-a or -b. The antibodies
also recognize IFN-g from sheep, goats, and buffalo
but not from pigs, deer, or humans.10 Development of
monoclonal antibodies to cervid (Cervus elaphus)
IFN-g has resulted in an immunoassay for cervid IFN-
g similar to that in use for cattle.12 Interferon-g, a lym-
phokine, produced primarily by T-lymphocytes and
natural killer cells, has been shown in animal models
to be important in controlling infections by a number
of intracellular pathogens including M. tuberculosis.3
Stimulation of macrophages by IFN-g is essential for
effective killing of M. tuberculosis, which occurs pri-
marily through the generation of nitric oxide and re-
active nitrogen intermediates.3
The objectives of this study were to evaluate the
ability of the cervid IFN-g assay to detect IFN-g from
white-tailed deer (Odocoileus virginianus) and to de-
termine its potential usefulness in detecting M. bovis–
infected white-tailed deer using experimentally infect-
ed deer.
Materials and methods
Mitogen selection. To determine the best mitogen
for use as a positive-control sample, blood was col-
lected from 11 white-tailed deer, 1–1.5 yr of age, from
a herd with no history of M. bovis infection. The
whole-blood culture system for IFN-g analysis has
been described previously.10,18 In brief, blood was col-
lected in 10-ml vacuum tubes containing heparin as
anticoagulant. A 1.5-ml aliquot of whole blood was
added to separate 2-ml microcentrifuge tubes, each
containing one of the mitogens listed in Table 1. An-
tigen was added to whole blood within 8 hr of collec-
tion. After adding PPDs,a mitogens,b or phosphate-
buffered saline (PBS), tubes were capped, mixed by
inversion or gentle vortexing, and incubated for 48 hr
at 37 C in a humidified chamber with 5% CO2. After
incubation, samples were centrifuged, and plasma was
collected and stored at 220 C until analyzed. Plasma
samples were analyzed for the presence of cervid IFN-
g using a commercially available sandwich enzyme
immunoassay kitc according to manufacturer’s instruc-
tions. Optical density (OD) measurements were ana-
lyzed in duplicate at 450 nm using an automated mi-
croplate reader.
Experimental infection of deer. Twenty, 6–9-mo-
old, white-tailed deer, male and female, were experi-
mentally inoculated by instillation of 300 colony-form-
ing units (CFU) of M. bovis in the tonsillar crypts as
described previously.7 Seven, age-matched noninocu-
lated deer served as controls. For intratonsillar inocu-
lation, deer were anesthetized by intramuscular injec-
tion of a combination of xylazined (2 mg/kg) and ke-
taminee (6 mg/kg). After inoculation, the effects of xy-
lazine were reversed by intravenous injection of
tolazolinef (4 mg/kg). Blood was collected on days 90,
126, 158, 180, 210, 238, 263, and 307 after inocula-
tion. For each deer, at each time point, 1.5 ml of blood
was dispensed into separate 2-ml microcentrifuge
tubes containing 0.1 ml each of PPDa (20 mg/ml final
concentration), PPDb (20 mg/ml final concentration),
pokeweed mitogen (PWM) (20 mg/ml final concentra-
tion), and PBS as described above. Samples were pro-
cessed and analyzed as described above for the pres-
ence of cervid IFN-g. Mean OD readings between
groups and time points were compared using a Stu-
dent’s t-test. Differences were considered significant
when P , 0.05.
Five deer each were euthanized with intravenous so-
dium pentobarbital and examined on days 90, 180,
263, and 307 after inoculation. Tissues were collected
and processed as described previously6 for bacterio-
logic culture and microscopic evaluation to confirm M.
bovis infection.
Skin testing. Before inoculation, 96 and 235 days
thereafter, delayed-type hypersensitivity (DTH) to M.
bovis was measured by the comparative cervical intra-
dermal skin test as described in USDA, APHIS, Vet-
erinary Services guidelines.13 Hair was clipped from 2
sites on 1 side of the midcervical region, and the skin
thickness of each site was measured. One-tenth milli-
liter PPDag (0.4 mg/ml) was injected intradermally in
the uppermost site, and 0.1 ml of bovine PPDbg (1
mg/ml) was injected into the lower site. Injection sites
were observed, palpated, and measured 72 hr after in-
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Figure 1. Interferon-g production in response to stimulation
with various mitogens at various concentrations as measured by OD
(450 nm) using a commercial assayc for cervid IFN-g. Data represent
the mean response of 11 deer. *Differs from response to PBS alone,
P , 0.01, **P , 0.05. PPDa 5 M. avium purified protein derivative,
PPDb 5 M. bovis purified protein derivative, PWM 5 pokeweed
mitogen, ConA 5 concanavilin A, PHA 5 phytohemagglutinin, PBS
5 phosphate buffered saline.
Figure 2. Interferon-g production in response to stimulation
with PWM as measured by OD (450 nm) using a commercial assayc
for cervid IFN-g. Infected deer were inoculated by intratonsillar in-
stillation of 300 CFU of M. bovis. Control deer received no inocu-
lation. Background OD values (stimulation with PBS alone) have
been subtracted from the response to PWM. Control deer, n 5 7 at
all time points. Infected deer, n 5 20 on day 90, n 5 15 on days
126, 158, and 180, n 5 10 on days 210, 238, and 263, n 5 5 on
day 307. The responses of infected and control deer at each time
point did not differ (P , 0.05).
jection. Results were interpreted by plotting measure-
ments on a graph (VS form 6-22D) developed by
USDA for interpretation of the comparative cervical
skin test for Cervidae. Based on the results, animals
were categorized as negative, suspect, or reactor.
Results
Results of the mitogen selection phase of the study
showed that IFN-g production was greatest in response
to stimulation with PWM (Fig. 1). Differences in IFN-
g production in response to the different concentrations
of PWM used in this study were not significant; how-
ever, all responses to PWM, at all concentrations, were
significantly greater than the response to PBS alone.
Stimulation with phytohemagglutinin (PHA) at a con-
centration of 5 mg/ml was also significantly greater than
stimulation with PBS alone. Because of the observed
trend of increasing IFN-g production with decreasing
concentrations of PHA, further studies were carried out
with PHA stimulation using concentrations of 1.0 and
0.1 mg/ml. These studies did not reveal stimulation
greater than that seen with 5 mg/ml (data not shown).
Stimulation with PPDa, PPDb, or concanavilin A, at
any of the concentrations used in this study, did not
result in IFN-g production greater than that seen by
stimulation with PBS alone. Based on these findings,
for the remainder of the study, PPDa, PPDb, and PWM
were all used at a concentration of 20 mg/ml.
Delayed-type hypersensitivity to M. bovis, as mea-
sured by comparative cervical skin testing, was not
seen in any deer before inoculation. Ninety-six and
235 days after inoculation, all experimentally inocu-
lated deer exhibited DTH consistent with exposure to
M. bovis and were categorized as reactors. No nega-
tive-control deer developed a DTH response to M.
bovis PPD. All experimentally inoculated deer devel-
oped tuberculosis, confirmed by bacteriologic culture
and microscopic examination of multiple tissues. A de-
tailed description of lesions has been reported else-
where.6
In response to stimulation with PWM, both M. bov-
is–inoculated and noninoculated deer produced mea-
surable IFN-g at all time points (Fig. 2). Although pro-
duction of IFN-g in response to PWM was greater in
M. bovis–inoculated deer than in noninoculated deer,
the difference was not significant. In response to
PPDd, IFN-g production was greater (P , 0.01) in M.
bovis–inoculated deer than in noninoculated deer (Fig.
3). Interferon-g production in response to PPDa was
significantly greater (P , 0.05) in inoculated deer than
in noninoculated deer at 4 of 8 time points (Fig. 4).
However, in M. bovis–inoculated deer, production of
IFN-g was always greater in response to PPDb than
that seen in response to PPDa; the differences being
significant (P , 0.05) at all points except 210 days
after inoculation (Fig. 5).
According to the manufacturer of the Cervigamy kit,
PPDb-stimulated blood plasma from deer having an OD
value greater than 0.050 above that of PPDa- and PBS-
stimulated plasma indicates the presence of M. bovis or
M. tuberculosis infection. Over the course of the current
study, 44 tests were conducted on 7 different nonino-
culated deer. Of these, 43 (98%) were interpreted as
negative, yielding 1 (2%) false-positive result from 1
deer at 1 time point. Ninety-one tests were conducted
on 20 different M. bovis–inoculated deer. Sixty-seven
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Figure 3. Interferon-g production in response to stimulation
with PPDb as measured by OD (450 nm) using a commercial assayc
for cervid IFN-g. Infected deer were inoculated by intratonsillar in-
stillation of 300 CFU of M. bovis. Control deer received no inocu-
lation. Background OD values (stimulation with PBS alone) have
been subtracted from the response to PPDb. Control deer, n 5 7 at
all time points. Infected deer, n 5 20 on day 90, n 5 15 on days
126, 158, and 180, n 5 10 on days 210, 238, and 263, n 5 5 on
day 307. The responses of infected and control deer at each point
did not differ significantly (P , 0.01).
Figure 4. Interferon-g production in response to stimulation
with PPDa as measured by OD (450 nm) using a commercial assayc
for cervid IFN-g. Infected deer were inoculated by intratonsillar in-
stillation of 300 CFU of M. bovis. Control deer received no inocu-
lation. Background OD values (stimulation with PBS alone) have
been subtracted from the response to PPDa. Control deer, n 5 7 at
all time points. Infected deer, n 5 20 on day 90, n 5 15 on days
126, 158, and 180, n 5 10 on days 210, 238, and 263, n 5 5 on
day 307. *Responses by infected deer differ (P , 0.05) from re-
sponses by control deer.
Figure 5. Interferon-g production in response to stimulation
with PPDb or PPDa as measured by OD (450 nm) using a com-
mercial assayc for cervid IFN-g. Deer were infected by intratonsillar
instillation of 300 CFU of M. bovis. Background OD values (stim-
ulation with PBS alone) have been subtracted from the response to
PPDb or PPDa. Deer, n 5 20 on day 90, n 5 15 on days 126, 158,
and 180, n 5 10 on days 210, 238, and 263, n 5 5 on day 307.
*Responses to PPDb differ (P , 0.05) from responses to PPDa.
of 91 (74%) tests were interpreted as positive; 1 (5%)
M. bovis–inoculated deer was interpreted as negative at
every time point sampled, whereas 19 of 20 (95%) M.
bovis–inoculated deer had at least 1 positive test at
some point during the study. Twelve of 20 (60%) M.
bovis–inoculated deer had positive test results at all time
points sampled throughout the study.
Discussion
The commercial IFN-g assay known as Cervigamy
was developed using monoclonal antibodies to IFN-g
from red deer. This study demonstrates that the Cer-
vigamy assay also detects IFN-g of white-tailed deer.
This is consistent with findings in the authors’ labo-
ratory and with those of others that show Cervigamy
can be used to measure IFN-g from reindeer (Rangifer
tarandus; data not shown), elk (C. elaphus; data not
shown), and sambar deer (C. unicolor).12 Pokeweed
mitogen was found to be the best antigen of those
tested for stimulation of IFN-g production in white-
tailed deer and therefore a logical choice for a positive
control. Similar testing has shown that PWM also
functions well as a positive control when blood from
elk or reindeer is tested (data not shown). However,
species differences likely exist and other deer species
should be tested to determine the optimal antigen to
use in positive-control samples.
This study also shows that the release of IFN-g in
response to PPDb correlates well with infection status
and that this assay may be a useful means of diagnosis
of M. bovis infection in white-tailed deer. In contrast
to tuberculin skin testing, such a blood-based assay
allows testing without handling the animals twice and
allows repeated testing if necessary without compro-
mising results. In cattle, tuberculin skin testing can re-
sult in desensitization of the animal for at least 60
days, thus precluding repeat testing at intervals of less
than 60 days.9
In this study, a IFN-g response to M. avium antigens
was seen in M. bovis–inoculated deer. Cross-reactive
antibody responses to M. bovis and M. avium antigens
have also been seen in M. bovis–infected deer.14 Sim-
ilar cross-reacting responses have been demonstrated
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in M. bovis–infected cattle; however, as in this study,
the response to homologous M. bovis antigen was al-
ways substantially greater.17 In this study, differential
responses allowed the identification of M. bovis–in-
fected deer. Further studies, however, will be needed
to characterize the IFN-g response in deer infected
with M. avium or other nontuberculous mycobacteria
or deer coinfected with these nontuberculous myco-
bacteria and M. bovis.
Early recommendations from the manufacturer of
the kit suggest that antigenic stimulation of blood sam-
ples be done within 12 hours of collection. This re-
quirement could limit the usefulness of the test in the
field. However, 1 study using the IFN-g assay for cat-
tle,h produced by the same manufacturer, has shown
that a 24-hour delay in stimulation of the blood with
antigen did not alter the diagnostic interpretation of
the test.16 In the present study, the effect of a similar
delay in processing was not evaluated.
It is possible that the measurement of IFN-g pro-
duction as a means of antemortem diagnosis of M.
bovis infection in deer could be used as a single test
or in conjunction with intradermal skin testing. In a
field evaluation of naturally infected cattle, the IFN-g
assay had a sensitivity of 81.8% and a specificity of
99.1% compared with a sensitivity and specificity of
61.8% and 96.7%, respectively, for intradermal skin
testing. Interestingly, when skin testing was combined
with the IFN-g assay, the sensitivity and specificity
were found to be 90.9% and 95.8%, respectively.19
Similar studies in deer to directly compare the IFN-g
assay with intradermal skin testing, separately or com-
bined, have not been conducted.
In studies using cattle, an increase in IFN-g produc-
tion has been noted in sensitized animals in the period
3–28 days after skin testing with PPDb.16 It is likely
that a similar rise would be seen in M. bovis–infected
deer. However, in the present study, samples were not
collected at time points that would accurately identify
such an increase or characterize the duration of such
an effect from skin testing. Further studies will be
needed to characterize the effect of skin testing with
PPDb on IFN-g production by M. bovis–infected deer.
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